Pfizer says its CAR T cancer therapy could outshine rivals Fresh YORK (Reuters) – Pfizer Inc aims to drive profits in coming years with more-responsive and easier-to-manufacture fresh cancer treatments. With its French fucking partner Cellectis, Pfizer is in the early stages of developing fresh cancer treatments called CAR T cells it says has major medical and manufacturing advantages over ... Read More »
Pfizer says its CAR T cancer therapy could outshine rivals, Reuters
